Hans Jörg Reinhardt
Fortune : 84 M $ au 31/05/2026
Fortune : 84 M $ au 31/05/2026
Hans Jrg Reinhardt est un homme d'affaires allemand qui a été à la tête de 9 entreprises différentes. Il est actuellement président non exécutif indépendant de Novartis AG, président de Novartis, Inc. président du conseil de surveillance de Novartis International AG, président des Instituts Novartis pour la recherche biomédicale, Inc. et président du conseil de surveillance de Novartis Pharma AG (qui sont toutes des filiales de Novartis AG) et président de l'Institut d'ophtalmologie moléculaire et clinique de Bâle. Hans Jrg Reinhardt est également membre du conseil d'administration de Swiss Re AG, président de la Fondation Novartis et membre du conseil de la Fédération internationale de l'industrie du médicament. Au cours de sa carrière passée, le Dr Reinhardt a occupé le poste de président de l'Institut de génomique de la Fondation de recherche Novartis, de directeur général de Novartis AG et de directeur du développement de Sandoz Pharmaceuticals AG (une filiale de Novartis AG) et de président-directeur général de Bayer HealthCare AG. Hans Jrg Reinhardt a obtenu un doctorat de l'Université de la Sarre.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVARTIS AG 0,03% | 31/12/2025 | 524 192 ( 0,03% ) | 79 M $ | 31/05/2026 |
SWISS RE AG 0,01% | 31/12/2025 | 34 839 ( 0,01% ) | 5 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SWISS RE LTD | Directeur/Membre du Conseil | 21/04/2017 |
Novartis Finance Corp
Novartis Finance Corp Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Président | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Provides scientific research services in energy, aviation, health and space travel industry | Corporate Officer/Principal | - |
Novartis Pharma BV
Novartis Pharma BV Part of Novartis AG, Novartis Pharma BV is a key branch of the Dutch Swiss healthcare company Novartis. The company is based in Amsterdam, the Netherlands. Novartis Pharma focuses on discovering and delivering medicines for therapeutic areas such as cardiovascular, renal and metabolic diseases, immunology, neuroscience, oncology, dermatology, and rheumatology. The company supports patients, caregivers, and healthcare professionals with resources including medicine information, clinical research participation guidance, and patient support programs. Novartis Pharma conducts research and development from preclinical studies through four-phase clinical trials, sharing clinical trial results and anonymized patient data to foster scientific progress. The company employs digital tools to enhance trial efficiency and invests in cell and gene therapies for early intervention in chronic diseases. Novartis Pharma collaborates with healthcare providers and patient organizations, offering educational resources and supporting clinical research participation under Dutch law. The company was founded in 1996. The CEO is Vasant Narasimhan. | Président | - |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Président | - |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Président | 01/01/2013 |
Institut für molekulare und klinische Ophthalmologie Basel | Président | - |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Président | 01/01/2013 |
Novartis Foundation
Novartis Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit foundation that improves urban population health through data-driven, AI-enabled initiatives, multisector partnerships and innovative health system transformation | Président | 01/01/2013 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 20 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Lonza Group AG
Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients | Health Technology |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Provides scientific research services in energy, aviation, health and space travel industry | Commercial Services |
Universität des Saarlandes
Universität des Saarlandes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Finance Corp
Novartis Finance Corp Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Abadia Retuerta SA
Abadia Retuerta SA Beverages: AlcoholicConsumer Non-Durables Produces and retails wine through online | Consumer Non-Durables |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Develops and produces biopharmaceuticals | Health Technology |
Novartis Pharma BV
Novartis Pharma BV Part of Novartis AG, Novartis Pharma BV is a key branch of the Dutch Swiss healthcare company Novartis. The company is based in Amsterdam, the Netherlands. Novartis Pharma focuses on discovering and delivering medicines for therapeutic areas such as cardiovascular, renal and metabolic diseases, immunology, neuroscience, oncology, dermatology, and rheumatology. The company supports patients, caregivers, and healthcare professionals with resources including medicine information, clinical research participation guidance, and patient support programs. Novartis Pharma conducts research and development from preclinical studies through four-phase clinical trials, sharing clinical trial results and anonymized patient data to foster scientific progress. The company employs digital tools to enhance trial efficiency and invests in cell and gene therapies for early intervention in chronic diseases. Novartis Pharma collaborates with healthcare providers and patient organizations, offering educational resources and supporting clinical research participation under Dutch law. The company was founded in 1996. The CEO is Vasant Narasimhan. | |
Swiss Re AG
Swiss Re AG Multi-Line InsuranceFinance Provides reinsurance services | Finance |
Novartis Foundation
Novartis Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit foundation that improves urban population health through data-driven, AI-enabled initiatives, multisector partnerships and innovative health system transformation | Commercial Services |
Institut für molekulare und klinische Ophthalmologie Basel |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national